APA (7th ed.) Citation

Janeth E. Araujo-Cárdenas, Miguel A. Rodríguez-Ruiz, Jaime A. López-Valdez, Rosa I. Rodríguez-Téllez, Yanelly Garfias-Gómez, Israel Parra-Ortega, & Genaro Patiño-López. (2023). Myosin 1g as a high-risk biomarker in a pediatric patient with lineage switch from acute lymphoblastic leukemia to myeloid phenotype. Permanyer.

Chicago Style (17th ed.) Citation

Janeth E. Araujo-Cárdenas, Miguel A. Rodríguez-Ruiz, Jaime A. López-Valdez, Rosa I. Rodríguez-Téllez, Yanelly Garfias-Gómez, Israel Parra-Ortega, and Genaro Patiño-López. Myosin 1g as a High-risk Biomarker in a Pediatric Patient with Lineage Switch from Acute Lymphoblastic Leukemia to Myeloid Phenotype. Permanyer, 2023.

MLA (9th ed.) Citation

Janeth E. Araujo-Cárdenas, et al. Myosin 1g as a High-risk Biomarker in a Pediatric Patient with Lineage Switch from Acute Lymphoblastic Leukemia to Myeloid Phenotype. Permanyer, 2023.